Mobile

Prospective randomised comparison of granulocyte colony-stimulating factor (G-CSF) (filgrastim) secondary prophylaxis versus conservative management of chemotherapy-induced neutropenia to maintain dos...

Mise à jour : Il y a 4 ans
Référence : ISRCTN89698860

Prospective randomised comparison of granulocyte colony-stimulating factor (G-CSF) (filgrastim) secondary prophylaxis versus conservative management of chemotherapy-induced neutropenia to maintain dose intensity in chemotherapy for breast cancer

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

http://www.cancerresearchuk.org/cancer-help/trials/a-trial-using-gcsf-to-try-to-reduce-the-risk-of-infection-in-people-having-chemotherapy-for-breast-cancer

Critère d'inclusion

  • Breast

Liens